Target intelligence / Profile preview

Ocular surface mucin and glycocalyx

Molecular classification
Mucin, Glycoprotein, Other
01

Overview

The ocular surface mucin and glycocalyx layer is a complex, multi-component structure that coats the corneal and conjunctival epithelia, playing a vital role in maintaining ocular surface health and tear film stability (Uchino, 2018; Gipson, 2004). It consists of membrane-associated mucins (MUC1, MUC4, MUC16) that form the glycocalyx and secreted gel-forming mucins (primarily MUC5AC) produced by conjunctival goblet cells (Argueso et al., 2021; Willcox, 2014). This layer provides essential lubrication, facilitates surface wetting, and acts as a robust physical and chemical barrier against pathogens, allergens, and environmental toxins (Uchino, 2018; Gipson, 2004). In diseases such as dry eye disease (DED), Sjögren's syndrome, and ocular surface inflammation, the expression and glycosylation of these mucins are significantly altered, leading to barrier disruption and epithelial damage (Uchino, 2018; Argueso et al., 2021). Therapeutic agents like rebamipide and diquafosol target this layer by stimulating mucin production and secretion, thereby restoring the protective glycocalyx and improving tear film quality (Uchino, 2018; BenchChem, 2026).

Other names
Tear film mucin layerCorneal glycocalyxConjunctival glycocalyxMucous layer of the tear filmOcular surface mucinsTear film mucin/glycocalyx layer on corneal and conjunctival epithelium
02

Mechanism of action

Stimulation of mucin secretion from goblet cells (mucin secretagogues), upregulation of membrane-associated mucin expression in epithelial cells via EGFR or P2Y2 pathways, and provision of mucin-mimetic lubrication and barrier support.

03

Biological functions

LubricationHydrationBarrier functionPathogen exclusionSurface wettingOsmosensingAnti-adhesion
04

Disease associations

Dry Eye DiseaseSjögren's syndromeOcular surface diseaseOcular allergyInfectionStevens-Johnson syndromeOcular graft-versus-host disease
05

Safety considerations

Ocular irritationBlurred visionForeign body sensationHypersensitivity to preservativesEctodomain shedding by bacterial proteases
06

Interacting drugs

Rebamipide

4 more in the full profile.

07

Biomarkers

Mucin 5AC (MUC5AC) levelsGoblet cell density (GCD)Tear film break-up time (TBUT)Rose bengal staining scoreGalectin-3 concentration in tears

Beyond the preview

Go deeper on Ocular surface mucin and glycocalyx.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular surface mucin and glycocalyx.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call